Trellis SessionStart ✓ — starting bounded worker execution for slice59n. Reading the assigned context and plan first.Context notes Source of Truth is still TODO; locating 冻结包72 and related D001 research within the workspace.Found package 72 (`pap-54a1b836e37a6cef7c155e26`). Extracting its units and cross-referencing official EX / flow controls.Package ordinal 72 in the raw frozen plan is 失访, not viral/TB — checking the accepted ~138-package numbering used in recent slices.Package 72 matches viral/TB. Cross-referencing official EX criteria, flow controls, and matrix rows for p803–p813.Enough evidence for the read-only clinical expectation matrix. Emitting the worker report now.

# Execution Output: phase5-slice59n-20260827 - worker_01

## Boundary And Context Check

- Role: `worker_01` / finite code executor; no manager; no conference; no peer review.
- Assigned item only: 只读核对冻结包72 ↔ 官方排除标准/流程表来源关系，形成逐项临床预期与停止条件；不修改临床源文件。
- Initial read: `context/phase5-slice59n-20260827_execution_context.md`, `plans/codex_execution_phase5-slice59n-20260827.md`.
- Context `Source Of Truth` still `TODO`; no production paths authorized. Additional workspace reads were required to locate 冻结包72 and cross-chapter controls (recorded below).
- Writes: none. Clinical sources untouched. Runner report path not edited by tools.
- Not claiming final clinical/regulatory acceptance.

## Work Performed

1. Resolved **current** 冻结包72 from slice59i rebaseline plan (not the obsolete 217-package ordinal72=失访, nor slice58i-v2 ordinal72=补救治疗).
2. Extracted 12 owned units `body.p802`–`body.p813` and checked context for EX/flow anchors.
3. Mapped owned assessment text to matrix / official-flow controls:
   - EX-09 结核、EX-22 病毒学/梅毒
   - 流程必做14 病毒学、流程必做15 结核
   - 跨章节行：病毒学有效期与反射性复核；结核CT/随机门控；结核预防/禁用/复测
4. Built item-by-item clinical expectations + replay **stop conditions** (reject gates), separating evidence / inference / recommendation / uncertainty.

## Artifacts And Evidence

### Package identity (evidence)

| Field | Value |
|---|---|
| Plan | `artifacts/.../slice59i.../frozen_phase_plan.json` → `plan_id=papl-40b1237a22e538a278b4fd5e` (131 packages) |
| Package | `package_ordinal=72`, `package_id=pap-3a57e1ae15a1a44c3ea68a1e` |
| Phase | `selected_phase=phase_ii`, `opposite_phase=phase_iii` |
| Protocol SHA | `362443131f0d384c82c80f6a37396084f7d3301b51162201749c0488b0f2dd98` |
| Owned | 12 units / 44 context / 68 frozen spans |
| Owned refs | `body.p802`…`body.p813` under 研究评估和程序 → 病毒学检查 / 结核筛查（p802 落在实验室检查） |

### Cross-chapter source map (evidence)

| Control | Kind | Primary sources | Relation to pkg72 |
|---|---|---|---|
| EX-09 结核感染筛查及预防治疗风险 | official_eligibility | `body.p649`–`p653`,`p655` | **Not in pkg72 context**. Matrix row77/78 = `supplementary_requirement` / `further_explanation` → EX-09 |
| EX-22 乙肝/丙肝/HIV/梅毒 | official_eligibility | `body.p685`–`p689` | **Not in pkg72 context**. Judgment uses pkg72 reflexive/panel results |
| 流程必做14 病毒学 | required_procedure | `body.t5.r18` + `body.p328` | **Not in pkg72 context**. Row76 supplements flow14 with validity/reflex |
| 流程必做15 结核 | required_procedure | `body.t5.r19` + `body.p329` | **Not in pkg72 context**. Row77/78 further explain flow15 |
| 病毒学结果有效期与反射性复核 | other_section | `body.p804`,`p805` | **Owned by pkg72** |
| 结核阳性后CT评估与随机门控 | other_section | `body.p807`–`p809` | **Owned by pkg72** |
| 结核预防/禁用/不确定复测 | other_section | `body.p811`–`p813` | **Owned by pkg72** |

Context check: none of EX/flow refs above appear in package72 `context_units` (only table headers `t5.r0`/`t6.r0`, phase visit scaffolding, `p765` “除给药时长外评估一致”, lab note atoms from `p801`, etc.).

### Panel / wording deltas (evidence)

- Flow footnote `p328` panel: HBsAg, HBcAb, HCVAb, HIVAb, 梅毒特异性抗体 + conditional HBV-DNA / HCV-RNA / 梅毒非特异性 + 研究者治愈判断.
- Assessment `p804` panel: same core **plus** 乙肝表面抗体、乙肝e抗原、乙肝e抗体； adds **首次给药前28天内可接受、筛选/基线无需再查**.
- `p805` restates conditional reflexives + same 28-day validity.
- TB flow `p329`: 筛选期 IGRA（QFT或T-SPOT）only.
- Assessment TB adds CT if IGRA+, active/latent randomization gates, prophylaxis ≥4w before first dose, 禁利福平/利福喷丁, 不确定可复测1次.

### structure_unit_id note (evidence)

For `p804`–`p813`, current frozen-plan `structure_unit_id` ≠ older matrix `structure_unit_id` (DRIFT). Stable join key for replay is **`source_ref`**, not historical `su-*`.

### 逐项临床预期（owned units）

| # | source_ref | Unit role | Clinical expectation (for replay/control closure) | Linked official/flow controls |
|---|---|---|---|---|
| 1 | `body.p802` | Boundary spill (实验室检查“其他检测”) | **Not** a viral/TB screening obligation. Expect disposition as non-target / out-of-family lab note. | None for viral/TB |
| 2 | `body.p803` | Section title「病毒学检查」 | Structural heading only; no standalone obligation. | Points into flow14 / EX-22 family |
| 3 | `body.p804` | Base viral panel + **first_dose−28d** validity | Must preserve full listed analytes; must preserve 28-day window and “筛选/基线无需再次检查”. Must **not** delete flow14 core panel; must **not** silently make HBsAb/HBeAg/HBeAb into EX-22 triggers. | Supplements 流程必做14; feeds EX-22 inputs |
| 4 | `body.p805` | Conditional reflexives + 28d validity | Conditional only: HBsAg− & HBcAb+ → HBV-DNA; HCVAb+ → HCV-RNA; 梅毒特异+ → 非特异. Same 28d window. Must not promote all reflexives to unconditional AND. | Aligns with `p328` conditionals; EX-22 uses DNA/RNA/非特异 results |
| 5 | `body.p806` | Section title「结核筛查」 | Heading only. | Points into flow15 / EX-09 family |
| 6 | `body.p807` | IGRA+ → 胸部CT | If IGRA positive, CT required to classify active vs latent. Missing CT after IGRA+ = incomplete. | Supplements EX-09 & flow15 |
| 7 | `body.p808` | Active TB → **不得随机** | Hard stop: any activity evidence → cannot randomize; **no** prophylaxis exception. | Hardens EX-09 active branches + random gate |
| 8 | `body.p809` | Latent TB → no random unless **随机前≥4周**适当治疗 | Preserve **randomization_date** 4-week anchor (do not rewrite solely to first_dose). | Complements EX-09 latent exception (which uses 首次给药前≥4周) |
| 9 | `body.p810` | 「注：」 marker | No obligation; binds following list items. | — |
| 10 | `body.p811` | Latent prophylaxis start **首次给药前≥4周** + consent to complete course; full course need not finish pre-dose | Preserve **first_dose_date** 4-week start + consent; do not require full course completion pre-dose. | Matches EX-09 exception arm |
| 11 | `body.p812` | 禁利福平 **或** 利福喷丁 for TB prophylaxis | Drug prohibition must remain; applies when prophylaxis used. | Same as EX-09 `p655` |
| 12 | `body.p813` | IGRA indeterminate → **at most 1** retest | Cap=1; second indeterminate feeds EX-09 latent definition with 无症状. | Explains EX-09 “连续两次不确定” path |

### Cross-chapter clinical expectations (must close outside owned text)

**流程必做14（筛选 X）**  
- Expect: screening-visit viral workup complete; conditional reflexives when triggered; syphilis cure judgment when nonspecific path applies.  
- Stop if: screening X missing; reflexive omitted when trigger present; researcher syphilis judgment missing when required.

**流程必做15（筛选 X）**  
- Expect: screening IGRA (QFT or T-SPOT) result present.  
- Stop if: IGRA missing before eligibility/randomization decisions that depend on it.

**EX-22**  
- Exclude if: HBsAg+ **OR** (HBcAb+ AND HBV-DNA>ULN) **OR** (HCVAb+ AND HCV-RNA>ULN) **OR** HIVAb+ **OR** (梅毒特异+ without exception).  
- Exception **only** for syphilis: 非特异阴性 **AND** 研究者判断既往已治愈.  
- Stop if: EX triggers rewritten; HBV/HCV treated as Ab-only exclude; syphilis exception applied to HBV/HCV/HIV; 28d validity used to waive EX positivity.

**EX-09**  
- Exclude on any of: active TB history; investigator signs/symptoms; CT current/prior active; IGRA+ latent; two consecutive indeterminates without symptoms — unless allowed latent exception.  
- Latent exception: completed adequate LTBI treatment **OR** (prophylaxis started ≥4w before first dose **AND** consent to finish). Exception does **not** waive active-TB branches.  
- Stop if: active TB allowed to randomize; exception applied to active; rifampin/rifapentine prophylaxis allowed; dual anchors 随机前4周 vs 首次给药前4周 collapsed/lost.

### Time anchors that must remain distinct

| Anchor | Source | Binding |
|---|---|---|
| 首次给药前28天内 | `p804`,`p805` | Viral result validity |
| 随机分组前至少4周治疗 | `p809` | Latent → randomization gate |
| 首次给药前至少4周开始预防 | `p811` + EX-09 | Latent prophylaxis start |
| 筛选期 | flow14/15, EX wording | Procedure performance / EX “筛选访视时” |

### Replay / repair **停止条件**（reject）

1. **SOURCE_MISSING**: any of flow14/15, EX-09, EX-22, or `p804`–`p813` material obligations without source closure.  
2. **CONTEXT_BLIND_CROSS_CHAPTER**: treating pkg72 alone as sufficient when EX/flow refs are absent from package context.  
3. **PHASE_MISMATCH**: inventing II-only/III-only split for these assessment controls against `p765` shared-assessment statement without opposite-phase source.  
4. **LOGIC_WEAKENING**: dropping active-TB hard random ban; dropping drug bans; making reflexives optional when triggered; raising indeterminate retest above 1; dropping 28d viral window.  
5. **LOGIC_OVERREACH**: making HBsAb/HBeAg/HBeAb into EX-22 exclude criteria; making all reflexives unconditional; requiring full prophylaxis course before first dose.  
6. **SCOPE_CREEP**: repairing unrelated owned units outside viral/TB family (esp. converting `p802` into viral/TB rule).  
7. **IDENTITY_DRIFT**: joining solely on stale matrix `structure_unit_id` instead of `source_ref`.  
8. **DUPLICATE_COUNTING**: merging EX-09 / flow15 / assessment TB into one collapsed obligation that loses CT, random gate, prophylaxis, or retest atoms.

### Inference / recommendation (not acceptance)

- Inference: pkg72 is the correct **病毒学/结核** representative frozen batch for slice59n.  
- Recommendation for worker_02: configurable replay must attach **related control rows** (EX-09/22, flow14/15, cross rows76–78) by `source_ref` / matrix_row_id, not rely on package context radius alone.  
- Recommendation for worker_03: assert stop conditions above; fail on missing cross-chapter sources or weakened random/prophylaxis/validity logic.  
- Uncertainty: flow14 matrix obligations currently list reflexives in a flat AND; protocol text is conditional — Codex should decide whether gate enforces conditional DNF vs current matrix serialization. Also `p686` English gloss mislabels HBcAb as “surface antibody” in verbatim protocol text; do not “correct” clinical source.

## Commands And Observations

| Tool | Target | Observation |
|---|---|---|
| Read | execution context + plan | Work item = read-only pkg72 expectations; SoT TODO |
| Glob/Grep/Shell | phase-closure + artifacts | Located pkg72 in slice59i plan; discarded wrong ordinal72 identities |
| Python JSON extract | `frozen_phase_plan.json` pkg72 | 12 owned units p802–p813 viral/TB |
| Python + Read | control-matrix-closed + official-flow-controls | Mapped EX-09/22, flow14/15, cross rows76–78; confirmed EX/flow **absent** from pkg72 context |
| Python | unit-phase-evidence-view | Verbatim for p328/p329/EX TB & viral paragraphs |
| Write/Edit | — | **Not used** |

## Blockers Or Missing Environment

- No environment blocker for this read-only item.
- Soft gap: context SoT was TODO; identity taken from accepted slice59i frozen plan in-workspace. Codex should confirm that plan as the authoritative package72 for slice59n replay.
- Soft product tension (not fixable here): flow14 obligation AND vs conditional reflex text; `structure_unit_id` drift vs matrix.

## Rerun Requests Or Next Step

1. Codex: confirm `pap-3a57e1ae15a1a44c3ea68a1e` / ordinal72 on `papl-40b1237a22e538a278b4fd5e` as the slice59n representative package.  
2. Hand this expectation+stop matrix to **worker_02** as the clinical contract for configurable replay (attach EX/flow/cross rows; do not widen to full 131 packages).  
3. **worker_03**: encode stop conditions as independent regressions; reject on source miss, phase misfit, or logic weaken.  
4. No clinical source edits; no further worker_01 action unless Codex rejects the package identity or asks for a persisted non-report artifact path.
